28.25
price up icon1.53%   +0.45
 
loading
10x Genomics Inc stock is currently priced at $28.25, with a 24-hour trading volume of 1.11M. It has seen a +1.53% increased in the last 24 hours and a -22.22% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $27.85 pivot point. If it approaches the $28.30 resistance level, significant changes may occur.

10x Genomics Inc Stock (TXG) Financials Data

10x Genomics Inc (TXG) Revenue 2024

TXG reported a revenue (TTM) of $618.73 million for the quarter ending December 31, 2023, a +19.81% rise year-over-year.
loading

10x Genomics Inc (TXG) Net Income 2024

TXG net income (TTM) was -$255.10 million for the quarter ending December 31, 2023, a -53.67% decrease year-over-year.
loading

10x Genomics Inc (TXG) Cash Flow 2024

TXG recorded a free cash flow (TTM) of -$64.72 million for the quarter ending December 31, 2023, a +60.84% increase year-over-year.
loading

10x Genomics Inc (TXG) Earnings per Share 2024

TXG earnings per share (TTM) was -$2.17 for the quarter ending December 31, 2023, a -47.62% decline year-over-year.
loading

10x Genomics Inc Stock (TXG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Saxonov Serge
Chief Executive Officer
Feb 22 '24
Sale
46.34
2,821
130,737
847,560
Hindson Benjamin J.
See Remarks
Feb 22 '24
Sale
46.34
2,613
121,098
283,059
McAnear Justin J.
Chief Financial Officer
Feb 22 '24
Sale
46.34
1,865
86,432
95,240
Saxonov Serge
Chief Executive Officer
Feb 15 '24
Sale
48.87
5,000
244,332
850,381
Saxonov Serge
Chief Executive Officer
Feb 09 '24
Sale
49.53
1,000
49,530
855,381
Saxonov Serge
Chief Executive Officer
Jan 16 '24
Sale
45.24
4,000
180,956
856,381
Hindson Benjamin J.
See Remarks
Dec 28 '23
Option Exercise
11.48
8,334
95,674
285,672
Saxonov Serge
Chief Executive Officer
Dec 27 '23
Option Exercise
1.20
14,935
17,922
860,381
Saxonov Serge
Chief Executive Officer
Dec 14 '23
Sale
55.03
2,000
110,065
845,446
Saxonov Serge
Chief Executive Officer
Nov 24 '23
Sale
43.72
3,723
162,751
847,446
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products. The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. 10x Genomics, Inc. was founded in 2012 and is headquartered in Pleasanton, California.
health_information_services EVH
$30.36
price up icon 1.67%
$32.80
price down icon 0.73%
$6.935
price up icon 4.05%
$16.28
price up icon 0.62%
$24.93
price up icon 0.48%
Cap:     |  Volume (24h):